Evogene Ltd. EVGN
0.29 USD +0.02 (+6.09%)
At closeNov 10, 2026, 5:33 AM EST
0.28 -0.01 -4.07%
Pre-market · Nov 10, 5:33 AM ET
0.265 Day range 0.2998
0.25 52-week range 1.28
- YTD
- -73.86%
- 1 year
- -75.00%
News
prnewswire.com Evogene Schedules Third Quarter 2026 Financial Results Release Zoom conference call scheduled for November 19, 2026, 9:00 AM ET REHOVOT, Israel, Nov. 5, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational…
benzinga.com Evogene Announces Acute Graft-Versus-Host Disease As Target Indication For Its Internal Drug Discovery Program Advancing a First-in-Class Small-Molecule Therapeutic, Guided by World-Leading Experts, to Address a Multi-Billion-Dollar Unmet Need in Steroid-Refractory PatientsREHOVOT, Israel, Oct. 28, 2026…